|
1
|
Frieden IJ, Haggstrom AN, Drolet BA,
Mancini AJ, Friedlander SF, Boon L, Chamlin SL, Baselga E, Garzon
MC, Nopper AJ, et al: Infantile hemangiomas: Current knowledge,
future directions Proceedings of a research workshop on infantile
hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr
Dermatol. 22:383–406. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Darrow DH, Greene AK, Mancini AJ and
Nopper AJ: Section On Dermatology, Section On Otolaryngology-Head
And Neck Surgery, and Section On Plastic Surgery. Diagnosis and
management of infantile hemangioma. Pediatrics. 136:e1060–1104.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Drolet BA, Frommelt PC, Chamlin SL,
Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE,
Liberman L, et al: Initiation and use of propranolol for infantile
hemangioma: Report of a consensus conference. Pediatrics.
131:128–140. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Csoma ZR, Dalmády S, Ábrahám R, Rózsa T,
Rácz K and Kemény L: Infantile haemangioma: Clinical and
demographic characteristics, experiences in the treatment. Orv
Hetil. 158:1535–1544. 2017.PubMed/NCBI View Article : Google Scholar : (In Hungarian).
|
|
5
|
Maturo S and Hartnick C: Initial
experience using propranolol as the sole treatment for infantile
airway hemangiomas. Int J Pediatr Otorhinolaryngol. 74:323–325.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Léauté-Labrèze C, Hoeger P,
Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ,
Caceres H, Lopez Gutierrez JC, Ballona R, et al: A randomized,
controlled trial of oral propranolol in infantile hemangioma. N
Engl J Med. 372:735–746. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Léaute-Labrèze C, Boccara O,
Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G,
Gautier S, Ortis V, Lafon M, Montagne A, et al: Safety of oral
propranolol for the treatment of infantile hemangioma: A systematic
review. Pediatrics. 138(e20160353)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang L, Wu HW, Yuan W and Zheng JW:
Propranolol therapy for infantile hemangioma: Our experience. Drug
Des Devel Ther. 11:1401–1408. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Raphael MF, Breur JM, Vlasveld FA, Elbert
NJ, Liem YT, Kon M, Breugem CC and Pasmans SG: Treatment of
infantile hemangiomas: Therapeutic options in regard to side
effects and adverse events-a review of the literature. Expert Opin
Drug Saf. 15:199–214. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Léauté-Labrèze C, Harper JI and Hoeger PH:
Infantile haemangioma. Lancet. 390:85–94. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chang L, Gu Y, Yu Z, Ying H, Qiu Y, Ma G,
Chen H, Jin Y and Lin X: When to stop propranolol for infantile
hemangioma. Sci Rep. 7(43292)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Raphaël MF, de Graaf M, Breugem CC,
Pasmans SGMA and Breur JMPJ: Atenolol: A promising alternative to
propranolol for the treatment of hemangiomas. J Am Acad Dermatol.
65:420–421. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ábarzúa-Araya A, Navarrete-Dechent CP,
Heusser F, Retamal J and Zegpi-Trueba MS: Atenolol versus
propranolol for the treatment of infantile hemangiomas: A
randomized controlled study. J Am Acad Dermatol. 70:1045–1049.
2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bayart CB, Tamburro JE, Vidimos AT, Wang L
and Golden AB: Atenolol versus propranolol for treatment of
infantile hemangiomas during the proliferative phase: A
retrospective noninferiority study. Pediatr Dermatol. 34:413–421.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang Q, Xiang B, Chen S and Ji Y: Efficacy
and safety of oral atenolol for the treatment of infantile
haemangioma: A systematic review. Australas J Dermatol. 60:181–185.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu X, Qu X, Zheng J and Zhang L:
Effectiveness and safety of oral propranolol versus other
treatments for infantile hemangiomas: A meta-analysis. PLoS One.
10(e0138100)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Novoa M, Baselga E, Beltran S, Giraldo L,
Shahbaz A, Pardo-Hernandez H and Arevalo-Rodriguez I: Interventions
for infantile haemangiomas of the skin. Cochrane Database Syst Rev.
4(CD006545)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care
interventions: Explanation and elaboration. J Clin Epidemiol.
62:e1–e34. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Higgins JP and Green S (eds.): Cochrane
Handbook for Systematic Reviews of Interventions. John Wiley &
Sons, Ltd., Chichester, 2008.
|
|
20
|
Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS,
Hahn S, Jang BH and Son HJ: Testing a tool for assessing the risk
of bias for nonrandomized studies showed moderate reliability and
promising validity. J Clin Epidemiol. 66:408–414. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rao G, Lopez-Jimenez F, Boyd J, D'Amico F,
Durant NH, Hlatky MA, Howard G, Kirley K, Masi C, Powell-Wiley TM,
et al: Methodological standards for meta-analyses and qualitative
systematic reviews of cardiac prevention and treatment studies: A
scientific statement from the American heart association.
Circulation. 136:e172–e194. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sharma VK, Fraulin FO, Dumestre DO, Walker
L and Harrop AR: Beta-blockers for the treatment of problematic
hemangiomas. Can J Plast Surg. 21:23–28. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sun L, Sun B, Ma Y, et al: Comparison of
the efficacy and safety of propranolol and atenolol in the
treatment of infant hemangioma. Progress Modern Biomed. 18:108–112.
2018.
|
|
24
|
de Graaf M, Raphael MF, Breugem CC, Knol
MJ, Bruijnzeel-Koomen CA, Kon M, Breur JM and Pasmans SG: Treatment
of infantile haemangiomas with atenolol: Comparison with a
historical propranolol group. J Plast Reconstr Aesthet Surg.
66:1732–1740. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dakoutrou M, Alexopoulos A, Miligkos M,
Georgiadou E, Kanaka-Gantenbein C and Kakourou T: Atenolol
treatment for severe infantile hemangiomas: Comparison with a
propranolol group of our centre. J Eur Acad Dermatol Venereol.
33:e199–e200. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang Q, Xiang B, Ji Y, Li F, Xu Z and
Zhong L: Propranolol versus atenolol in the treatment of infantile
hemangioma: A comparative study. Chin J Dermatol. 49:683–687.
2016.
|
|
27
|
Ashraf R, Mahajan R, Abas M, Handa S,
Sinha A, De D and Sachdev N: Comparing the clinical, radiologic and
biochemical effectiveness of atenolol and propranolol in the
treatment of infantile hemangioma-a randomized controlled trial.
Social Science Research Network, Rochester, NY, 2019. https://ssrn.com/abstract=3353380.
|
